Zoetis Inc
NYSE:ZTS

Watchlist Manager
Zoetis Inc Logo
Zoetis Inc
NYSE:ZTS
Watchlist
Price: 175.34 USD -0.96%
Market Cap: 79.4B USD
Have any thoughts about
Zoetis Inc?
Write Note

Zoetis Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Zoetis Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Zoetis Inc
NYSE:ZTS
Cash & Cash Equivalents
$1.7B
CAGR 3-Years
-19%
CAGR 5-Years
-1%
CAGR 10-Years
11%
Johnson & Johnson
NYSE:JNJ
Cash & Cash Equivalents
$8.2B
CAGR 3-Years
20%
CAGR 5-Years
15%
CAGR 10-Years
-5%
Bristol-Myers Squibb Co
NYSE:BMY
Cash & Cash Equivalents
$7.9B
CAGR 3-Years
-16%
CAGR 5-Years
-24%
CAGR 10-Years
5%
Pfizer Inc
NYSE:PFE
Cash & Cash Equivalents
$1.1B
CAGR 3-Years
-19%
CAGR 5-Years
-18%
CAGR 10-Years
-8%
Merck & Co Inc
NYSE:MRK
Cash & Cash Equivalents
$14.6B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Cash & Cash Equivalents
$3.4B
CAGR 3-Years
-4%
CAGR 5-Years
17%
CAGR 10-Years
1%

See Also

What is Zoetis Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.7B USD

Based on the financial report for Sep 30, 2024, Zoetis Inc's Cash & Cash Equivalents amounts to 1.7B USD.

What is Zoetis Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
11%

Over the last year, the Cash & Cash Equivalents growth was -2%. The average annual Cash & Cash Equivalents growth rates for Zoetis Inc have been -19% over the past three years , -1% over the past five years , and 11% over the past ten years .

Back to Top